Year |
Citation |
Score |
2023 |
Figueiredo TH, Aroniadou-Anderjaska V, Apland JP, Rossetti K, Braga MF. Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure. Experimental Biology and Medicine (Maywood, N.J.). 248: 612-623. PMID 37300407 DOI: 10.1177/15353702231171911 |
0.407 |
|
2023 |
Pidoplichko VI, Figueiredo TH, Braga MF, Pan H, Marini AM. Alpha-linolenic acid enhances the facilitation of GABAergic neurotransmission in the BLA and CA1. Experimental Biology and Medicine (Maywood, N.J.). 15353702231165010. PMID 37208920 DOI: 10.1177/15353702231165010 |
0.363 |
|
2020 |
Aroniadou-Anderjaska V, Apland JP, Figueiredo TH, De Araujo Furtado M, Braga MF. Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures. Neuropharmacology. 108298. PMID 32898558 DOI: 10.1016/j.neuropharm.2020.108298 |
0.386 |
|
2019 |
Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Braga MF. Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy. Neurobiology of Disease. PMID 30798006 DOI: 10.1016/j.nbd.2019.02.017 |
0.522 |
|
2017 |
Krishnan JKS, Figueiredo TH, Moffett JR, Arun P, Appu AP, Puthillathu N, Braga MF, Flagg T, Namboodiri AM. Brief isoflurane administration as a post-exposure treatment for organophosphate poisoning. Neurotoxicology. PMID 28939237 DOI: 10.1016/j.neuro.2017.09.009 |
0.461 |
|
2016 |
Miller SL, Aroniadou-Anderjaska V, Pidoplichko VI, Figueiredo TH, Apland JP, Krishnan JK, Braga MF. The M1 muscarinic receptor antagonist VU0255035 delays the development of status epilepticus after organophosphate exposure and prevents hyperexcitability in the basolateral amygdala. The Journal of Pharmacology and Experimental Therapeutics. PMID 27799295 DOI: 10.1124/Jpet.116.236125 |
0.639 |
|
2016 |
Long Ii RP, Aroniadou-Anderjaska V, Prager EM, Pidoplichko VI, Figueiredo TH, Braga MF. Repeated Isoflurane Exposures Impair Long-Term Potentiation and Increase Basal GABAergic Activity in the Basolateral Amygdala. Neural Plasticity. 2016: 8524560. PMID 27313904 DOI: 10.1155/2016/8524560 |
0.59 |
|
2016 |
Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Prager EM, Pidoplichko VI, Miller SL, Braga MF. Long-term neuropathological and behavioral impairments after exposure to nerve agents. Annals of the New York Academy of Sciences. PMID 27002925 DOI: 10.1111/Nyas.13028 |
0.73 |
|
2016 |
Krishnan JK, Arun P, Appu AP, Vijayakumar N, Figueiredo TH, Braga MF, Baskota S, Olsen CH, Farkas N, Dagata J, William H FI, Moffett JR, Namboodiri AM. Intranasal Delivery of Obidoxime to the Brain Prevents Mortality and CNS Damage from Organophosphate Poisoning. Neurotoxicology. PMID 26751814 DOI: 10.1016/j.neuro.2015.12.020 |
0.325 |
|
2015 |
Prager EM, Bergstrom HC, Wynn GH, Braga MF. The basolateral amygdala γ-aminobutyric acidergic system in health and disease. Journal of Neuroscience Research. PMID 26586374 DOI: 10.1002/Jnr.23690 |
0.656 |
|
2015 |
Miller SL, Aroniadou-Anderjaska V, Figueiredo TH, Prager EM, Almeida-Suhett CP, Apland JP, Braga MF. A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists. Toxicology and Applied Pharmacology. 284: 204-16. PMID 25689173 DOI: 10.1016/J.Taap.2015.02.008 |
0.724 |
|
2015 |
Prager EM, Figueiredo TH, Long RP, Aroniadou-Anderjaska V, Apland JP, Braga MF. LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety. Neuropharmacology. 89: 11-8. PMID 25204221 DOI: 10.1016/j.neuropharm.2014.08.014 |
0.67 |
|
2014 |
Apland JP, Aroniadou-Anderjaska V, Figueiredo TH, Rossetti F, Miller SL, Braga MF. The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302. The Journal of Pharmacology and Experimental Therapeutics. 351: 359-72. PMID 25157087 DOI: 10.1124/Jpet.114.217299 |
0.657 |
|
2014 |
Prager EM, Pidoplichko VI, Aroniadou-Anderjaska V, Apland JP, Braga MF. Pathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala. Neurotoxicology. 44: 335-43. PMID 25150775 DOI: 10.1016/j.neuro.2014.08.007 |
0.657 |
|
2014 |
Almeida-Suhett CP, Prager EM, Pidoplichko V, Figueiredo TH, Marini AM, Li Z, Eiden LE, Braga MF. Reduced GABAergic inhibition in the basolateral amygdala and the development of anxiety-like behaviors after mild traumatic brain injury. Plos One. 9: e102627. PMID 25047645 DOI: 10.1371/Journal.Pone.0102627 |
0.634 |
|
2014 |
Pidoplichko VI, Aroniadou-Anderjaska V, Prager EM, Figueiredo TH, Almeida-Suhett CP, Miller SL, Braga MF. ASIC1a activation enhances inhibition in the basolateral amygdala and reduces anxiety. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 3130-41. PMID 24573273 DOI: 10.1523/Jneurosci.4009-13.2014 |
0.688 |
|
2014 |
Prager EM, Aroniadou-Anderjaska V, Almeida-Suhett CP, Figueiredo TH, Apland JP, Rossetti F, Olsen CH, Braga MF. The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior. Neuropharmacology. 81: 64-74. PMID 24486384 DOI: 10.1016/j.neuropharm.2014.01.035 |
0.651 |
|
2013 |
Pidoplichko VI, Prager EM, Aroniadou-Anderjaska V, Braga MF. α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability. Journal of Neurophysiology. 110: 2358-69. PMID 24004528 DOI: 10.1152/jn.01030.2012 |
0.641 |
|
2013 |
Prager EM, Aroniadou-Anderjaska V, Almeida-Suhett CP, Figueiredo TH, Apland JP, Braga MF. Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure. Neurotoxicology. 38: 84-90. PMID 23817175 DOI: 10.1016/j.neuro.2013.06.006 |
0.67 |
|
2013 |
Apland JP, Aroniadou-Anderjaska V, Figueiredo TH, Green CE, Swezey R, Yang C, Qashu F, Braga MF. Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration. The Journal of Pharmacology and Experimental Therapeutics. 344: 133-40. PMID 23042954 DOI: 10.1124/Jpet.112.198689 |
0.778 |
|
2012 |
Aroniadou-Anderjaska V, Pidoplichko VI, Figueiredo TH, Almeida-Suhett CP, Prager EM, Braga MF. Presynaptic facilitation of glutamate release in the basolateral amygdala: a mechanism for the anxiogenic and seizurogenic function of GluK1 receptors. Neuroscience. 221: 157-69. PMID 22796081 DOI: 10.1016/j.neuroscience.2012.07.006 |
0.658 |
|
2011 |
Figueiredo TH, Aroniadou-Anderjaska V, Qashu F, Apland JP, Pidoplichko V, Stevens D, Ferrara TM, Braga MF. Neuroprotective efficacy of caramiphen against soman and mechanisms of its action. British Journal of Pharmacology. 164: 1495-505. PMID 21486285 DOI: 10.1111/J.1476-5381.2011.01427.X |
0.797 |
|
2011 |
Williams LR, Aroniadou-Anderjaska V, Qashu F, Finne H, Pidoplichko V, Bannon DI, Braga MF. RDX binds to the GABA(A) receptor-convulsant site and blocks GABA(A) receptor-mediated currents in the amygdala: a mechanism for RDX-induced seizures. Environmental Health Perspectives. 119: 357-63. PMID 21362589 DOI: 10.1289/Ehp.1002588 |
0.778 |
|
2011 |
Figueiredo TH, Qashu F, Apland JP, Aroniadou-Anderjaska V, Souza AP, Braga MF. The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology. The Journal of Pharmacology and Experimental Therapeutics. 336: 303-12. PMID 20962029 DOI: 10.1124/Jpet.110.171835 |
0.782 |
|
2010 |
Apland JP, Figueiredo TH, Qashu F, Aroniadou-Anderjaska V, Souza AP, Braga MF. Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology. Neurotoxicology. 31: 485-92. PMID 20570628 DOI: 10.1016/J.Neuro.2010.05.014 |
0.767 |
|
2010 |
Manion ST, Figueiredo TH, Aroniadou-Anderjaska V, Braga MF. Electroconvulsive shocks exacerbate the heightened acoustic startle response in stressed rats. Behavioral Neuroscience. 124: 170-4. PMID 20141293 DOI: 10.1037/a0018258 |
0.719 |
|
2010 |
Qashu F, Figueiredo TH, Aroniadou-Anderjaska V, Apland JP, Braga MF. Diazepam administration after prolonged status epilepticus reduces neurodegeneration in the amygdala but not in the hippocampus during epileptogenesis. Amino Acids. 38: 189-97. PMID 19127342 DOI: 10.1007/S00726-008-0227-2 |
0.792 |
|
2009 |
Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Qashu F, Braga MF. Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus. Neurotoxicology. 30: 772-6. PMID 19591865 DOI: 10.1016/J.Neuro.2009.06.011 |
0.779 |
|
2009 |
Fritsch B, Qashu F, Figueiredo TH, Aroniadou-Anderjaska V, Rogawski MA, Braga MF. Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis. Neuroscience. 163: 415-29. PMID 19540312 DOI: 10.1016/J.Neuroscience.2009.06.034 |
0.8 |
|
2009 |
Braga MF, Aroniadou-Anderjaska V, Li H, Rogawski MA. Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons. The Journal of Pharmacology and Experimental Therapeutics. 330: 558-66. PMID 19417176 DOI: 10.1124/Jpet.109.153908 |
0.515 |
|
2009 |
Apland JP, Aroniadou-Anderjaska V, Braga MF. Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro. Neuroscience. 159: 380-9. PMID 19136046 DOI: 10.1016/j.neuroscience.2008.11.053 |
0.508 |
|
2008 |
Aroniadou-Anderjaska V, Fritsch B, Qashu F, Braga MF. Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy. Epilepsy Research. 78: 102-16. PMID 18226499 DOI: 10.1016/J.Eplepsyres.2007.11.011 |
0.768 |
|
2007 |
Aroniadou-Anderjaska V, Qashu F, Braga MF. Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders. Amino Acids. 32: 305-15. PMID 17048126 DOI: 10.1007/S00726-006-0415-X |
0.79 |
|
2004 |
Braga MF, Aroniadou-Anderjaska V, Li H. The physiological role of kainate receptors in the amygdala. Molecular Neurobiology. 30: 127-41. PMID 15475623 DOI: 10.1385/Mn:30:2:127 |
0.486 |
|
2004 |
Braga MF, Pereira EF, Mike A, Albuquerque EX. Pb2+ via protein kinase C inhibits nicotinic cholinergic modulation of synaptic transmission in the hippocampus. The Journal of Pharmacology and Experimental Therapeutics. 311: 700-10. PMID 15226386 DOI: 10.1124/jpet.104.070466 |
0.561 |
|
2004 |
Braga MF, Aroniadou-Anderjaska V, Manion ST, Hough CJ, Li H. Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 45-58. PMID 14532911 DOI: 10.1038/Sj.Npp.1300297 |
0.742 |
|
2003 |
Braga MF, Aroniadou-Anderjaska V, Xie J, Li H. Bidirectional modulation of GABA release by presynaptic glutamate receptor 5 kainate receptors in the basolateral amygdala. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 442-52. PMID 12533604 DOI: 10.1523/Jneurosci.23-02-00442.2003 |
0.448 |
|
2002 |
Braga MF, Aroniadou-Anderjaska V, Post RM, Li H. Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala: implications for its effects in seizure and affective disorders. Neuropharmacology. 42: 522-9. PMID 11955522 DOI: 10.1016/S0028-3908(01)00198-8 |
0.51 |
|
2000 |
Alkondon M, Braga MF, Pereira EF, Maelicke A, Albuquerque EX. alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus. European Journal of Pharmacology. 393: 59-67. PMID 10770998 DOI: 10.1016/S0014-2999(00)00006-6 |
0.535 |
|
1999 |
Braga MF, Pereira EF, Albuquerque EX. Nanomolar concentrations of lead inhibit glutamatergic and GABAergic transmission in hippocampal neurons. Brain Research. 826: 22-34. PMID 10216193 DOI: 10.1016/S0006-8993(99)01194-4 |
0.553 |
|
1999 |
Braga MF, Pereira EF, Marchioro M, Albuquerque EX. Lead increases tetrodotoxin-insensitive spontaneous release of glutamate and GABA from hippocampal neurons. Brain Research. 826: 10-21. PMID 10216192 DOI: 10.1016/S0006-8993(99)01193-2 |
0.726 |
|
1998 |
Albuquerque EX, Pereira EF, Braga MF, Matsubayashi H, Alkondon M. Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine. Toxicology Letters. 102: 211-8. PMID 10022256 DOI: 10.1016/S0378-4274(98)00309-9 |
0.548 |
|
1998 |
Albuquerque EX, Pereira EF, Braga MF, Alkondon M. Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of alpha 7 receptors. Journal of Physiology, Paris. 92: 309-16. PMID 9789829 DOI: 10.1016/S0928-4257(98)80039-9 |
0.531 |
|
1997 |
Camara AL, Braga MF, Rocha ES, Santos MD, Cortes WS, Cintra WM, Aracava Y, Maelicke A, Albuguergue EX. Methamidophos: an anticholinesterase without significant effects on postsynaptic receptors or transmitter release. Neurotoxicology. 18: 589-602. PMID 9291508 |
0.342 |
|
Show low-probability matches. |